tea polyphenols, quercetin, and genistein have been widely studied for their potential chemopreventive applications. Some flavonoids were first shown to be apoptotic in human lymphoid leukemic cells and human carcinoma cells. Similar observations have since been extended to lung tumor cell lines, colon cancer cells, breast cancer cells, prostate cancer cells, stomach cancer cells, brain tumor cells, head and neck squamous carcinoma, and cervical cancer cells. Recent epidemiologic studies have shown good correlation between dietary intake of carotenoids and reduced risk of cancer and cardiovascular diseases.Tomato is rich in various carotenoids. Lycopene is the precursor of β-carotene in tomato, which accumulates after the lycopene cyclase gene is downregulated during ripening. Lycopene and β-carotene can induce apoptosis in prostate cancer cells and malignant lymphoblast cells. Caffeic acid phenethyl ester, an active phenolic component extracted from honey bee propolis, blocks tumorigenesis in a two stage model of mouse skin cancer. Caffeic acid phenethyl ester has been reported induce apoptosis in HL-60 leukemic cells and mouse epidermal JB6 Cl 41 cells. Curcumin induces apoptosis in colon carcinoma cells, leukemic cells, prostate cancer cells, melanoma cells, and breast cancer cells. The use of garlic as anticancer agent has long been established. The allylsulfur compounds derived from garlic have significant anti-proliferate activity against human cancers. Diallylsulfide and diallyldisulfide induce apoptosis in non-small cell lung cancer cells and in prostate cancer and breast cancer cells. With our increased understanding of the chemistry and biology of nutraceuticals, the nutraceutical research will shift more into the area of chemoprevention. It is suggested that the following considerations should be taken on the future use of nutraceuticals for disease prevention: 1) synthesis of analogues; to further increase the efficacy of a promising nutraceutical. One can use it as a chemical template for combinatorial synthesis. 2) identification of molecular targets. With the molecular targets of nutraceuticals being known, it may be possible to develop more refined chemicals that specifically target those commonly shared sites. 3) synergistic effect: with the understanding of the molecular action of each nutraceutical, one can test possible synergistic effects on chemo-prevention by using two or more nutraceuticals or derivatives. 
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